摘要
目的:探讨重症急性胰腺炎并发腹腔间隔室综合征的治疗经验。方法:选择我院2004年2月至2011年8月收治的重症急性胰腺炎并发腹腔间隔室综合征患者60例,随即分为对照组与治疗组,每组30例,对照组患者给予常规治疗,治疗组患者给予甲磺酸加贝酯进行治疗,两组患者的疗程均为7d。治疗后观察两组患者的症状和体征改善状况,统计患者并发症发生情况。结果:治疗后,患者腹胀、腹痛、发热、肠蠕动、上腹压痛等症状和体征恢复正常时间均明显短于对照组(P<0.05);各种并发症发生率明显低于对照组(P<0.05)。结论:甲磺酸加贝酯治疗重症急性胰腺炎并发腹腔间隔室综合征的临床疗效确切,能够明显提高患者生存质量,值得临床推广应用。
Objective： To discuss the clinical experience of severe acute pancreatitis complicated with abdominal compartment syndrome.Method：60 cases with severe acute pancreatitis complicated with abdominal compartment syndrome admitted to hospital from Feb.2004 to Aug.2011 were randomly divided into control group and treatment group,the control group was given the conventional therapy;the treatment group was given the gabexate mesilat;7 days after treatment,Observed the clinical efficacy and occurrence of complications of two groups.Result： After treatment,the recovery time of abdominal distension,abdominal pain,fever,bowel movements,abdominal tenderness and other symptoms and signs were significantly shorter than that of the control group（P0.05）;the incidences of a variety of complications were significantly lower than that of the control group（P0.05）.Conclusion： The clinical efficacy of gabexate mesilat improved significantly,could improve patient quality of life and should be widely applied.
出处
《河北医学》
CAS
2012年第11期1572-1574,共3页
Hebei Medicine
